R&D Productivity Ranking Methodology
Catenion's methodology for evaluating R&D productivity of the world's 30 largest public pharmaceutical companies, as judged by sales.
You may also be interested in...
Catenion updates its annual list of the year's top pharma R&D performers, based on R&D productivity and growth.
A decision by health technology assessment body NICE opens the door to broaden the use of adalimumab, etanercept and infliximab by using them to treat moderate as well as severe rheumatoid arthritis.
India’s Granules has grown through increased market penetration of its existing products as well as new product launches. The company is planning to invest in expanding its API capacity, finished dosages and a new multiple unit pellet facility.